Back
Global X Enhanced S&P 500 Covrd Call ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
52
USCL.TO
Global X Enhanced S&P 500 Covrd Call ETF
Last Price:
22.58
Seasonality Move:
9.76%
Sell
43
VKTX
Viking Therapeutics
Last Price:
64.63
Seasonality Move:
38.04%
Buy
52
Global X Enhanced S&P 500 Covrd Call ETF (USCL.TO)
is a Buy
Is Global X Enhanced S&P 500 Covrd Call ETF a Buy, Sell or Hold?
- The current Global X Enhanced S&P 500 Covrd Call ETF [USCL.TO] share price is $22.58. The Score for USCL.TO is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- USCL.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.63. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
USCL.TO Stock Price Chart
What is Global X Enhanced S&P 500 Covrd Call ETF's stock price today?
-
The Global X Enhanced S&P 500 Covrd Call ETF share price today is $22.58
The current trend is moderately bearish and USCL.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
USCL.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.43 | Buy |
| Chaikin Money Flow: | 11422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.19 - 23.03) | Sell |
| Bollinger Bands (100): | (21.42 - 22.5) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -1563854 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.12 - 71.48) | Sell |
| Bollinger Bands (100): | (53.04 - 66.68) | Buy |
USCL.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.77 | Sell |
| 20-day SMA: | 22.78 | Sell |
| 50-day SMA: | 22.17 | Buy |
| 200-day SMA: | 21.53 | Buy |
| 8-day EMA: | 22.67 | Sell |
| 20-day EMA: | 22.65 | Sell |
| 50-day EMA: | 22.33 | Buy |
| 200-day EMA: | 21.49 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.35 | Sell |
| 20-day SMA: | 67.56 | Sell |
| 50-day SMA: | 64.43 | Buy |
| 200-day SMA: | 60.03 | Buy |
| 8-day EMA: | 68.57 | Sell |
| 20-day EMA: | 67.8 | Sell |
| 50-day EMA: | 65.05 | Sell |
| 200-day EMA: | 55.42 | Buy |
Global X Enhanced S&P 500 Covrd Call ETF Earnings Growth & USCL.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Global X Enhanced S&P 500 Covrd Call ETF Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||